The rise of artificial intelligence has produced serial writers to science and medical journals, most likely using chatbots to boost the number of citations they’ve published.
OpenEvidence, a company described as the “ChatGPT of doctors”, which has just raised US$200 million, increasing its market valuation.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback